Mark Battaglini

Mark Battaglini is the Chief Strategy Officer at Alliance for Regenerative Medicine, where Mark is responsible for global policy, government affairs, communications, and alliance development activities. Previously, Mark held various senior roles at companies such as bluebird bio, Cubist Pharmaceuticals, and Amylin Pharmaceuticals. Mark also has a background in law, having served as a Lieutenant in the Judge Advocate General Corp. in the United States Navy. Mark holds a BS in Management from Boston College and a JD from Seton Hall University School of Law.